Humacyte Inc is screened out under 3 exclusion reasons spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Excluded under our animal testing screen. As a pharmaceutical, biotechnology, or life sciences company, this firm's product development and regulatory processes require animal testing under current FDA/EMA protocols. This is a policy-based exclusion — we do not invest in companies whose business operations depend on animal testing, regardless of scale.
Prior pipeline note: Humacyte Inc is a biotechnology company whose product development pipeline involves animal testing as part of its preclinical research and regulatory compliance process. The company's work in developing human acellular tissue-based products requires animal studies to demonstrate safety and efficacy.
Research Sources
2 organizations
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.